Manulife Reports Third Quarter 2024 Results
Manulife Financial (MFC) reported strong Q3 2024 results with record core earnings of $1.8 billion, up 4% from Q3 2023. Key highlights include: core EPS of $1.00 (up 7%), net income of $1.8 billion (up $0.8 billion), and a LICAT ratio of 137%. The company saw significant growth with APE sales up 40%, new business CSM up 47%, and NBV up 39%. Global Wealth and Asset Management achieved net inflows of $5.2 billion, compared to net outflows of $0.8 billion in Q3 2023. The company maintained strong financial metrics with a core ROE of 16.6% and has returned over $2 billion to shareholders through share buybacks since the start of 2024.
Manulife Financial (MFC) ha riportato risultati solidi per il terzo trimestre del 2024, con utili core record di 1,8 miliardi di dollari, in aumento del 4% rispetto al terzo trimestre del 2023. I punti salienti includono: EPS core di 1,00 dollari (in aumento del 7%), reddito netto di 1,8 miliardi di dollari (in aumento di 0,8 miliardi di dollari) e un rapporto LICAT del 137%. L'azienda ha registrato una crescita significativa con vendite APE in aumento del 40%, CSM per nuove attività in aumento del 47% e NBV in aumento del 39%. La Global Wealth e Asset Management ha ottenuto afflussi netti di 5,2 miliardi di dollari, rispetto a deflussi netti di 0,8 miliardi di dollari nel terzo trimestre del 2023. L'azienda ha mantenuto solidi indicatori finanziari con un ROE core del 16,6% e ha restituito oltre 2 miliardi di dollari agli azionisti attraverso riacquisti di azioni dall'inizio del 2024.
Manulife Financial (MFC) reportó resultados sólidos en el tercer trimestre de 2024, con ganancias centrales récord de 1.8 mil millones de dólares, un aumento del 4% en comparación con el tercer trimestre de 2023. Los aspectos destacados incluyen: EPS central de 1.00 dólares (un aumento del 7%), ingresos netos de 1.8 mil millones de dólares (un aumento de 0.8 mil millones de dólares) y un índice LICAT del 137%. La empresa vio un crecimiento significativo con ventas APE en aumento del 40%, CSM del nuevo negocio en aumento del 47% y NBV en aumento del 39%. Global Wealth y Asset Management lograron entradas netas de 5.2 mil millones de dólares, en comparación con salidas netas de 0.8 mil millones de dólares en el tercer trimestre de 2023. La empresa mantuvo métricas financieras sólidas con un ROE central del 16.6% y ha devuelto más de 2 mil millones de dólares a los accionistas a través de recompras de acciones desde principios de 2024.
매뉴라이프 파이낸셜 (MFC)는 2024년 3분기 강력한 실적을 발표하며, 18억 달러의 기록적인 핵심 수익을 기록했고, 이는 2023년 3분기 대비 4% 증가한 수치입니다. 주요 하이라이트로는: 핵심 EPS 1.00 달러 (7% 증가), 순이익 18억 달러 (8억 달러 증가), LICAT 비율 137%입니다. 이 회사는 APE 매출이 40% 증가하고 신규 비즈니스 CSM이 47% 증가하며 NBV가 39% 증가하는 상당한 성장을 목격했습니다. 글로벌 재산 및 자산 관리 부서는 2023년 3분기에 8억 달러의 순 유출과 비교하여 52억 달러의 순 유입을 달성했습니다. 이 회사는 핵심 ROE 16.6%의 강력한 재무 지표를 유지했으며, 2024년 초부터 주식 매입을 통해 주주에게 20억 달러 이상을 반환했습니다.
Manulife Financial (MFC) a annoncé des résultats solides pour le troisième trimestre 2024, avec des bénéfices centraux record de 1,8 milliard de dollars, en hausse de 4 % par rapport au troisième trimestre 2023. Les faits saillants comprennent : EPS central de 1,00 $ (en hausse de 7 %), revenu net de 1,8 milliard de dollars (en hausse de 0,8 milliard de dollars) et un ratio LICAT de 137 %. L'entreprise a connu une croissance significative avec des ventes APE en hausse de 40 %, un CSM pour les nouvelles affaires en hausse de 47 % et un NBV en hausse de 39 %. La gestion de patrimoine et d'actifs mondiale a réalisé des apports nets de 5,2 milliards de dollars, contre des sorties nettes de 0,8 milliard de dollars au troisième trimestre 2023. L'entreprise a maintenu des indicateurs financiers solides avec un ROE central de 16,6 % et a retourné plus de 2 milliards de dollars aux actionnaires par le biais de rachats d'actions depuis le début de 2024.
Manulife Financial (MFC) hat im dritten Quartal 2024 starke Ergebnisse bekannt gegeben, mit rekordverdächtigen Kerngewinnen von 1,8 Milliarden Dollar, was einem Anstieg von 4 % gegenüber dem dritten Quartal 2023 entspricht. Zu den wichtigsten Punkten gehören: Kern-EPS von 1,00 Dollar (7 % gestiegen), Nettoeinkommen von 1,8 Milliarden Dollar (um 0,8 Milliarden Dollar gestiegen) und ein LICAT-Verhältnis von 137 %. Das Unternehmen verzeichnete ein signifikantes Wachstum mit APE-Verkäufen, die um 40 % gestiegen sind, neuen Geschäft CSM, die um 47 % gestiegen sind, und NBV, das um 39 % gestiegen ist. Global Wealth und Asset Management konnten Nettozuflüsse von 5,2 Milliarden Dollar verzeichnen, im Vergleich zu Nettoabflüssen von 0,8 Milliarden Dollar im dritten Quartal 2023. Das Unternehmen hielt starke Finanzkennzahlen mit einem Kern-ROE von 16,6 % und hat seit Anfang 2024 über 2 Milliarden Dollar an die Aktionäre durch Aktienrückkäufe zurückgegeben.
- Record core earnings of $1.8 billion, up 4% year-over-year
- Net income increased by $0.8 billion to $1.8 billion
- Strong Global WAM performance with $5.2 billion net inflows
- APE sales growth of 40% and NBV growth of 39%
- Return of over $2 billion to shareholders through buybacks in 2024
- Core ROE of 16.6% demonstrating strong profitability
- U.S. segment core earnings declined 8%
- Canada APE sales decreased 20% year-over-year
- Impact of Global Minimum Taxes affecting earnings
Insights
Manulife delivered an impressive
- Global WAM achieved record core earnings with a
37% increase, driven by higher fee income and positive net flows of$5.2 billion - Asia segment showed robust growth with core earnings up
17% and record levels in APE sales, new business CSM and NBV - Book value per share increased
9% to$24.40
The company's financial position remains solid with a LICAT ratio of
The results reveal strong market positioning and execution across key business segments. Notable highlights include:
- Record insurance metrics with APE sales up
40% , demonstrating strong market demand and distribution effectiveness - Global Wealth segment attracted
$5.2 billion in net inflows, reversing previous outflows and indicating improved investor confidence - Expense efficiency ratio of
45.0% shows disciplined cost management
The strategic focus on high-net-worth offerings and digital transformation, particularly in Asia markets, positions the company well for continued growth. The expansion of AI capabilities and enhanced customer experience initiatives should drive further operational efficiencies.
TSX/NYSE/PSE: MFC SEHK: 945
C$ unless otherwise stated
Key highlights for the third quarter of 2024 ("3Q24") include:
- Core earnings2 of
, up$1.8 billion 4% on a constant exchange rate basis3 from the third quarter of 2023 ("3Q23") - Net income attributed to shareholders of
, up$1.8 billion from 3Q23$0.8 billion - Core EPS4 of
, up$1.00 7% 3 from 3Q23. EPS of , up$1.00 91% 3 from 3Q23 - Excluding the impact of Global Minimum Taxes ("GMT")5, core EPS4 was
, up$1.03 11% 3 from 3Q23 - Core ROE4 of
16.6% and ROE of16.6% - LICAT ratio6 of
137% - APE sales up
40% 7, new business CSM up47% 3 and new business value ("NBV") up39% 7 from 3Q238 - Global Wealth and Asset Management net inflows7 of
, up from net outflows of$5.2 billion in 3Q23$0.8 billion
"We continued to drive momentum and delivered strong results in the third quarter, evident in record total company core earnings, substantial top-line growth across our operating segments and steady growth in our book value per share. In Global WAM, we generated a
— Roy Gori, Manulife President & Chief Executive Officer
"We have made progress on our financial targets unveiled at our Investor Day this year. Core ROE of
— Colin Simpson, Manulife Chief Financial Officer
Results at a Glance
Quarterly Results | YTD Results | |||||
($ millions, unless otherwise stated) | 3Q24 | 3Q23 | Change3,7 | 2024 | 2023 | Change |
Net income attributed to shareholders | $ 1,839 | $ 1,013 | 82 % | $ 3,747 | $ 3,444 | 8 % |
Core earnings | $ 1,828 | $ 1,743 | 4 % | $ 5,319 | $ 4,911 | 8 % |
EPS ($) | $ 1.00 | $ 0.52 | 91 % | $ 1.97 | $ 1.76 | 11 % |
Core EPS ($) | $ 1.00 | $ 0.92 | 7 % | $ 2.84 | $ 2.55 | 12 % |
ROE | 16.6 % | 9.5 % | 7.1 pps | 11.3 % | 10.8 % | 0.5 pps |
Core ROE | 16.6 % | 16.8 % | -0.2 pps | 16.3 % | 15.7 % | 0.6 pps |
Book value per common share ($) | $ 24.40 | $ 22.42 | 9 % | $ 24.40 | $ 22.42 | 9 % |
Adjusted BV per common share ($)4 | $ 34.97 | $ 30.67 | 14 % | $ 34.97 | $ 30.67 | 14 % |
Financial leverage ratio (%)4 | 23.5 % | 25.2 % | -1.7 pps | 23.5 % | 25.2 % | -1.7 pps |
APE sales | $ 2,347 | $ 1,657 | 40 % | $ 6,137 | $ 4,890 | 26 % |
New business CSM | $ 759 | $ 507 | 47 % | $ 2,045 | $ 1,541 | 33 % |
NBV | $ 843 | $ 600 | 39 % | $ 2,235 | $ 1,694 | 32 % |
Global WAM net flows ($ billions) | $ 5.2 | $ (0.8) | - % | $ 12.0 | $ 5.8 | 110 % |
Results by Segment
Quarterly Results | YTD Results | |||||
($ millions, unless otherwise stated) | 3Q24 | 3Q23 | Change7 | 2024 | 2023 | Change |
Net income attributed to shareholders | $ 606 | $ 63 | 877 % | $ 1,300 | $ 543 | 136 % |
Core earnings | 453 | 390 | 17 % | 1,413 | 1,104 | 31 % |
APE sales | 1,372 | 835 | 64 % | 3,242 | 2,582 | 28 % |
New business CSM | 435 | 300 | 45 % | 1,148 | 845 | 38 % |
NBV | 481 | 310 | 55 % | 1,194 | 900 | 35 % |
Net income attributed to shareholders | $ 430 | $ 290 | 48 % | $ 782 | $ 826 | (5) % |
Core earnings | 412 | 408 | 1 % | 1,178 | 1,135 | 4 % |
APE sales | 343 | 431 | (20) % | 1,313 | 1,046 | 26 % |
New business CSM | 95 | 51 | 86 % | 241 | 154 | 56 % |
NBV | 143 | 153 | (7) % | 459 | 351 | 31 % |
Net income attributed to shareholders | $ 5 | $ 53 | (91) % | $ 23 | $ 327 | (93) % |
Core earnings | 302 | 329 | (8) % | 940 | 955 | (2) % |
APE sales | 97 | 79 | 23 % | 303 | 275 | 10 % |
New business CSM | 52 | 40 | 30 % | 178 | 187 | (5) % |
NBV | 34 | 25 | 36 % | 112 | 99 | 13 % |
Global WAM | ||||||
Net income attributed to shareholders | $ 498 | $ 318 | 55 % | $ 1,213 | $ 932 | 29 % |
Core earnings | 499 | 361 | 37 % | 1,255 | 968 | 29 % |
Gross flows ($ billions)7 | 41.3 | 34.3 | 19 % | 128.2 | 108.2 | 18 % |
Average AUMA ($ billions)7 | 963 | 813 | 16 % | 924 | 812 | 13 % |
Core EBITDA margin (%) | 27.8 % | 26.9 % | 90 bps | 26.6 % | 24.7 % | 190 bps |
Strategic Highlights
We are driving profitable top-line growth through product and distribution innovations
In Asia, we continued the rollout of Manulife Pro, our proprietary recognition and activation program for top-tier agents, to
In addition, we further enhanced our high-net-worth offerings with the launch of two innovative new products: Manulife Global Indexed UL PRO in our International High Net Worth business and Signature Indexed Income in
In the
In Global WAM, we announced the closing of a
We are elevating the customer experience with continued digital and AI enhancements
In Asia, we improved customer experience and the operational efficiency of our
Furthermore, we launched new mobile apps in
In the
In Global WAM, we launched an AI-powered planning tool in our wealth platform in Canada Retail to enhance support for advisors and their clients, delivering an elevated service experience through streamlined financial planning processes and personalized advice and solutions.
We are helping our customers live longer, healthier, and better lives
In
In the
Strong earnings driven by continued business growth and improved market experience14
Core earnings of
The increase reflected strong business growth led by Global WAM and
Asia core earnings were up17% , reflecting continued business growth momentum and benefits from updates to actuarial methods and assumptions in 2023 and 2024.- Global WAM core earnings hit a record level in 3Q24 and grew
37% , driven by higher net fee income from favourable market impacts and positive net flows, favourable tax true-ups and benefits, and continued expense discipline. Canada core earnings increased1% as strong business growth in Group Insurance more than offset the impact of less favourable claims experience in 3Q24.U.S. core earnings were down8% , primarily due to lower investment spreads, impact from the previously completed reinsurance transaction and the annual review of actuarial methods and assumptions, partially offset by a lower charge in the ECL provision and more favourable claims experience in life.- Corporate and Other core earnings decreased
, mainly due to the impact of GMT and higher interest on capital allocated to operating segments.$123 million
Net Income attributed to shareholders of
The
Record levels across all three insurance new business metrics for total company and Asia segment, and strong net inflows in Global WAM
Significant momentum continued into 3Q24 as the insurance business generated year-over-year growth of
Asia led with broad-based growth, generating64% ,45% and55% year-over-year growth in APE sales, new business CSM and NBV, respectively, reflecting higher sales volumes inHong Kong , mainlandChina ,Singapore andJapan . NBV margin7 remained resilient at38.8% .Canada delivered solid new business results; higher sales in participating life insurance and Group Insurance were more than offset by the non-recurrence of a large affinity market sale in 3Q23. APE sales and NBV were down20% and7% , respectively, while new business CSM increased86% due to strong individual insurance and segregated fund sales.U.S. delivered double-digit growth in APE sales, new business CSM and NBV of23% ,30% and36% , respectively, reflecting a rebound in demand from affluent customers for accumulation insurance products.
Global WAM net inflows of
- Retirement net inflows of
in 3Q24 increased from net outflows of$0.6 billion in 3Q23, primarily driven by the non-recurrence of a large-case retirement plan redemption in the$3.4 billion U.S. in 3Q23. - Retail net inflows of
in 3Q24 increased from net outflows of$3.9 billion in 3Q23, due to increased demand for investment products amid an equity market recovery and improved investor sentiment, as well as the onboarding of several new advisors in$0.2 billion Canada wealth. - Institutional Asset Management net inflows of
in 3Q24 decreased compared with net inflows of$0.7 billion in 3Q23, reflecting higher redemptions in fixed income mandates.$2.8 billion
Growth in new business continues to drive higher organic CSM and CSM balance
CSM15 was
CSM increased
Annual Review of Actuarial Methods and Assumptions
We completed our annual review of actuarial methods and assumptions, which resulted in a net favourable impact of a
__________________________________ | |
1. | Record levels of total company annualized premium equivalent ("APE") sales, new business contractual service margin ("new business CSM") and new business value ("NBV"). |
2. | Core earnings and post-tax contractual service margin net of NCI ("post-tax CSM net of NCI") are non-GAAP financial measures. For more information on non-GAAP and other financial measures, see "Non-GAAP and other financial measures" below and in our 3Q24 Management's Discussion and Analysis ("3Q24 MD&A"). |
3. | Percentage growth / declines in core earnings, diluted core earnings per common share ("core EPS"), diluted earnings (loss) per share ("EPS"), core EPS excluding the impact of GMT, new business contractual service margin net of NCI ("new business CSM"), and net income attributed to shareholders are stated on a constant exchange rate basis and are non-GAAP ratios. |
4. | Core EPS, core EPS excluding the impact of GMT, core ROE, core EBITDA margin, highest potential businesses core earnings contribution, expense efficiency ratio, adjusted book value per common share ("adjusted BV per common share") and financial leverage ratio are non-GAAP ratios. |
5. | On June 20, 2024, |
6. | Life Insurance Capital Adequacy Test ("LICAT") ratio of The Manufacturers Life Insurance Company ("MLI") as at September 30, 2024. LICAT ratio is disclosed under the Office of the Superintendent of Financial Institutions Canada's ("OSFI's") Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline. |
7. | For more information on annualized premium equivalent ("APE") sales, NBV, Global Wealth and Asset Management ("Global WAM") net flows, gross flows, average asset under management and administration ("average AUMA") and new business value margin ("NBV margin"), see "Non-GAAP and other financial measures" below. In this news release, percentage growth/decline in APE sales, NBV, net flows, gross flows and average AUMA are stated on a constant exchange rate basis. |
8. | Refer to "Results at a Glance" for 3Q24 and 3Q23 results. |
9. | As of October 31, 2024. |
10. | Manulife Pro is available in Singapore, Vietnam, Indonesia, Japan and Hong Kong. |
11. | Net promoter score ("NPS"). |
12. | Compared with registration in May 2024, prior to the soft launch of the app in June 2024. |
13. | Jianhui Zhao, Liying Xu, et al - Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019: BMJ Oncology 2023. |
14. | See section A1 "Profitability" in our 3Q24 MD&A for more information on notable items attributable to core earnings and net income attributed to shareholders. |
15. | Net of non-controlling interests ("NCI"). |
16. | This amount excludes the portion related to NCI. |
Quarterly Results Conference Call
Manulife will host a conference call and live webcast on its third quarter 2024 results on November 7, 2024, at 8:00 a.m. (ET). To access the conference call, dial 1-800-806-5484 or 1-416-340-2217 (Passcode: 3664682#). Please call in 15 minutes before the scheduled start time. You will be required to provide your name and organization to the operator. You may access the webcast at manulife.com/en/investors/results-and-reports.
The archived webcast will be available following the call at the same URL as above. A replay of the call will also be available until December 7, 2024, by dialing 1-800-408-3053 or 1-905-694-9451 (Passcode: 5071593#).
The Third Quarter 2024 Statistical Information Package is also available on the Manulife website at www.manulife.com/en/investors/results-and-reports.
This earnings news release should be read in conjunction with the Company's Third Quarter 2024 Report to Shareholders, including our unaudited interim Consolidated Financial Statements for the three and nine months ended September 30, 2024, prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board, which is available on our website at www.manulife.com/en/investors/results-and-reports.html. The Company's 3Q24 MD&A and additional information relating to the Company is available on the SEDAR+ website at http://www.sedarplus.ca and on the
Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.
Earnings
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
Quarterly Results | YTD Results | ||||
($ millions) | 3Q24 | 2Q24 | 3Q23 | 2024 | 2023 |
Core earnings | |||||
$ 619 | $ 647 | $ 522 | $ 1,923 | $ 1,484 | |
412 | 402 | 408 | 1,178 | 1,135 | |
411 | 415 | 442 | 1,278 | 1,285 | |
Global Wealth and Asset Management | 499 | 399 | 361 | 1,255 | 968 |
Corporate and Other | (113) | (126) | 10 | (315) | 39 |
Total core earnings | $ 1,828 | $ 1,737 | $ 1,743 | $ 5,319 | $ 4,911 |
Items excluded from core earnings: | |||||
Market experience gains (losses) | 186 | (665) | (1,022) | (1,258) | (1,657) |
Change in actuarial methods and assumptions that flow directly through income |
(199) |
- |
(14) |
(199) |
(14) |
Restructuring charge | (20) | - | - | (20) | - |
Reinsurance transactions, tax-related items and other | 44 | (30) | 306 | (95) | 204 |
Net income attributed to shareholders | $ 1,839 | $ 1,042 | $ 1,013 | $ 3,747 | $ 3,444 |
Non-GAAP and other financial measures
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of "specified financial measures" (as defined therein).
Non-GAAP financial measures include core earnings (loss); core earnings available to common shareholders; core earnings before income taxes, depreciation and amortization ("core EBITDA"); core expenses, core earnings available to common shareholders excluding the impact of GMT; core revenue; adjusted book value; post-tax contractual service margin; and post-tax contractual service margin net of NCI ("post-tax CSM net of NCI"). In addition, non-GAAP financial measures include the following stated on a constant exchange rate ("CER") basis: any of the foregoing non-GAAP financial measures; net income attributed to shareholders; and common shareholders' net income.
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); core EPS excluding the impact of Global Minimum Tax ("GMT"); highest potential businesses core earnings contribution; expense efficiency ratio; adjusted book value per common share; financial leverage ratio; core EBITDA margin; and percentage growth/decline on a constant exchange rate basis in any of the above non-GAAP financial measures and non-GAAP ratios; net income attributed to shareholders; diluted earnings per common share ("EPS"); and new business CSM.
Other specified financial measures include NBV; APE sales; gross flows; net flows; average assets under management and administration ("average AUMA"); new business value margin ("NBV margin"); and percentage growth/decline in these foregoing specified financial measures. In addition, explanations of the components of the CSM movement, other than the new business CSM were provided in the 3Q24 MD&A.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and other financial measures" in our 3Q24 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders – 3Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q24 | ||||||||
Global | Corporate | Total | ||||||
Income (loss) before income taxes | $ 1,059 | $ 578 | $ 18 | $ 519 | $ 167 | $ 2,341 | ||
Income tax (expenses) recoveries | ||||||||
Core earnings | (65) | (104) | (112) | (6) | (28) | (315) | ||
Items excluded from core earnings | 26 | (10) | 99 | (14) | (60) | 41 | ||
Income tax (expenses) recoveries | (39) | (114) | (13) | (20) | (88) | (274) | ||
Net income (post-tax) | 1,020 | 464 | 5 | 499 | 79 | 2,067 | ||
Less: Net income (post-tax) attributed to | ||||||||
Non-controlling interests | 130 | - | - | 1 | - | 131 | ||
Participating policyholders | 63 | 34 | - | - | - | 97 | ||
Net income (loss) attributed to shareholders (post-tax) | 827 | 430 | 5 | 498 | 79 | 1,839 | ||
Less: Items excluded from core earnings (post-tax) | ||||||||
Market experience gains (losses) | 213 | 16 | (204) | 28 | 133 | 186 | ||
Changes in actuarial methods and assumptions that flow directly through income | (5) | 2 | (202) | - | 6 | (199) | ||
Restructuring charge | - | - | - | (20) | - | (20) | ||
Reinsurance transactions, tax related items and other | - | - | - | (9) | 53 | 44 | ||
Core earnings (post-tax) | $ 619 | $ 412 | $ 411 | $ 499 | $ (113) | $ 1,828 | ||
Income tax on core earnings (see above) | 65 | 104 | 112 | 6 | 28 | 315 | ||
Core earnings (pre-tax) | $ 684 | $ 516 | $ 523 | $ 505 | $ (85) | $ 2,143 | ||
Core earnings, CER basis and U.S. dollars – 3Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q24 | ||||||
|
|
| Global | Corporate | Total | |
Core earnings (post-tax) | $ 619 | $ 412 | $ 411 | $ 499 | $ (113) | $ 1,828 |
CER adjustment(1) | - | - | - | - | - | - |
Core earnings, CER basis (post-tax) | $ 619 | $ 412 | $ 411 | $ 499 | $ (113) | $ 1,828 |
Income tax on core earnings, CER basis(2) | 65 | 104 | 112 | 6 | 28 | 315 |
Core earnings, CER basis (pre-tax) | $ 684 | $ 516 | $ 523 | $ 505 | $ (85) | $ 2,143 |
Core earnings (U.S. dollars) – Asia and U.S. segments Core earnings (post-tax)(3), US $ |
$ 453 |
$ 302 | ||||
CER adjustment US $(1) | - | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 453 | $ 302 |
(1) The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q24. |
(3) Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 3Q24. |
Reconciliation of core earnings to net income attributed to shareholders – 2Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q24 | ||||||
Global | Corporate | Total | ||||
Income (loss) before income taxes | $ 763 | $ 141 | $ 156 | $ 383 | $ (59) | $ 1,384 |
Income tax (expenses) recoveries | ||||||
Core earnings | (64) | (107) | (95) | (46) | (8) | (320) |
Items excluded from core earnings | (51) | 68 | 74 | 14 | (37) | 68 |
Income tax (expenses) recoveries | (115) | (39) | (21) | (32) | (45) | (252) |
Net income (post-tax) | 648 | 102 | 135 | 351 | (104) | 1,132 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 38 | - | - | 1 | - | 39 |
Participating policyholders | 28 | 23 | - | - | - | 51 |
Net income (loss) attributed to shareholders (post-tax) | 582 | 79 | 135 | 350 | (104) | 1,042 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (58) | (364) | (280) | (7) | 44 | (665) |
Changes in actuarial methods and assumptions that flow directly through income |
- |
- |
- |
- |
- |
- |
Restructuring charge | - | - | - | - | - | - |
Reinsurance transactions, tax related items and other | (7) | 41 | - | (42) | (22) | (30) |
Core earnings (post-tax) | $ 647 | $ 402 | $ 415 | $ 399 | $ (126) | $ 1,737 |
Income tax on core earnings (see above) | 64 | 107 | 95 | 46 | 8 | 320 |
Core earnings (pre-tax) | $ 711 | $ 509 | $ 510 | $ 445 | $ (118) | $ 2,057 |
Core earnings, CER basis and U.S. dollars – 2Q24
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q24 | ||||||
Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 647 | $ 402 | $ 415 | $ 399 | $ (126) | $ 1,737 |
CER adjustment(1) | 7 | - | (2) | (1) | 1 | 5 |
Core earnings, CER basis (post-tax) | $ 654 | $ 402 | $ 413 | $ 398 | $ (125) | $ 1,742 |
Income tax on core earnings, CER basis(2) | 65 | 107 | 95 | 46 | 8 | 321 |
Core earnings, CER basis (pre-tax) | $ 719 | $ 509 | $ 508 | $ 444 | $ (117) | $ 2,063 |
Core earnings ( Core earnings (post-tax)(3), US $ |
$ 472 |
$ 303 | ||||
CER adjustment US $(1) | 6 | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 478 | $ 303 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q24. |
Reconciliation of core earnings to net income attributed to shareholders – 3Q23
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q23 | ||||||
Global | Corporate | Total | ||||
Income (loss) before income taxes | $ 439 | $ 376 | $ 68 | $ 366 | $ (75) | $ 1,174 |
Income tax (expenses) recoveries | ||||||
Core earnings | (62) | (109) | (93) | (59) | 30 | (293) |
Items excluded from core earnings | (73) | 15 | 97 | 11 | 294 | 344 |
Income tax (expenses) recoveries | (135) | (94) | 4 | (48) | 324 | 51 |
Net income (post-tax) | 304 | 282 | 72 | 318 | 249 | 1,225 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 25 | - | - - - | 25 | ||
Participating policyholders | 195 | (8) | - - - | 187 | ||
Net income (loss) attributed to shareholders (post-tax) | 84 | 290 | 72 | 318 | 249 | 1,013 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (286) | (159) | (476) | (43) | (58) | (1,022) |
Changes in actuarial methods and assumptions that flow directly through income |
(157) |
37 |
106 |
- |
- |
(14) |
Restructuring charge | - | - | - - - | - | ||
Reinsurance transactions, tax related items and other | 5 | 4 | - - 297 | 306 | ||
Core earnings (post-tax) | $ 522 | $ 408 | $ 442 | $ 361 | $ 10 | $ 1,743 |
Income tax on core earnings (see above) | 62 | 109 | 93 | 59 | (30) | 293 |
Core earnings (pre-tax) | $ 584 | $ 517 | $ 535 | $ 420 | $ (20) | $ 2,036 |
Core earnings, CER basis and U.S. dollars – 3Q23
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q23 | ||||||
Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 522 | $ 408 | $ 442 | $ 361 | $ 10 | $ 1,743 |
CER adjustment(1) | 4 | - | 7 | 4 | 1 | 16 |
Core earnings, CER basis (post-tax) | $ 526 | $ 408 | $ 449 | $ 365 | $ 11 | $ 1,759 |
Income tax on core earnings, CER basis(2) | 62 | 109 | 95 | 59 | (30) | 295 |
Core earnings, CER basis (pre-tax) | $ 588 | $ 517 | $ 544 | $ 424 | $ (19) | $ 2,054 |
Core earnings ( | ||||||
Core earnings (post-tax)(3), US $ | $ 390 | $ 329 | ||||
CER adjustment US $(1) | (4) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 386 | $ 329 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 3Q23. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2024
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2024 | ||||||
Global | Corporate | Total | ||||
Income (loss) before income taxes | $ 2,416 | $ 1,100 | $ 20 | $ 1,328 | $ 113 | $ 4,977 |
Income tax (expenses) recoveries | ||||||
Core earnings | (196) | (302) | (310) | (110) | (3) | (921) |
Items excluded from core earnings | (108) | 66 | 322 | (3) | (162) | 115 |
Income tax (expenses) recoveries | (304) | (236) | 12 | (113) | (165) | (806) |
Net income (post-tax) | 2,112 | 864 | 32 | 1,215 | (52) | 4,171 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 223 | - | - | 2 | - | 225 |
Participating policyholders | 117 | 82 | - | - | - | 199 |
Net income (loss) attributed to shareholders (post-tax) | 1,772 | 782 | 32 | 1,213 | (52) | 3,747 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (95) | (439) | (1,018) | 27 | 267 | (1,258) |
Changes in actuarial methods and assumptions that flow directly through income |
(5) |
2 |
(202) |
- |
6 |
(199) |
Restructuring charge | - | - | - | (20) | - | (20) |
Reinsurance transactions, tax related items and other | (51) | 41 | (26) | (49) | (10) | (95) |
Core earnings (post-tax) | $ 1,923 | $ 1,178 | $ 1,278 | $ 1,255 | $ (315) | $ 5,319 |
Income tax on core earnings (see above) | 196 | 302 | 310 | 110 | 3 | 921 |
Core earnings (pre-tax) | $ 2,119 | $ 1,480 | $ 1,588 | $ 1,365 | $ (312) | $ 6,240 |
Core earnings, CER basis and U.S. dollars – YTD 2024
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD | 2024 | |||||
Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 1,923 | $ 1,178 | $ 1,278 | $ 1,255 | $ (315) | |
CER adjustment(1) | 15 | - | 3 | 2 | 1 | 21 |
Core earnings, CER basis (post-tax) | $ 1,938 | $ 1,178 | $ 1,281 | $ 1,257 | $ (314) | |
Income tax on core earnings, CER basis(2) | 197 | 302 | 312 | 110 | 3 | 924 |
Core earnings, CER basis (pre-tax) | $ 2,135 | $ 1,480 | $ 1,593 | $ 1,367 | $ (311) | |
Core earnings ( | ||||||
Core earnings (post-tax)(3), US $ | $ 1,413 | $ 940 | ||||
CER adjustment US $(1) | 6 | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 1,419 | $ 940 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up 2024 year-to-date core earnings. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2023
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2023 | ||||||
Global | Corporate | Total | ||||
Income (loss) before income taxes | $ 1,397 | $ 1,111 | $ 507 | $ 1,073 | $ 241 | $ 4,329 |
Income tax (expenses) recoveries | ||||||
Core earnings | (203) | (291) | (289) | (149) | 62 | (870) |
Items excluded from core earnings | (128) | 34 | 223 | 9 | 209 | 347 |
Income tax (expenses) recoveries | (331) | (257) | (66) | (140) | 271 | (523) |
Net income (post-tax) | 1,066 | 854 | 441 | 933 | 512 | 3,806 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 104 | - | - | 1 | - | 105 |
Participating policyholders | 229 | 28 | - | - | - | 257 |
Net income (loss) attributed to shareholders (post-tax) | 733 | 826 | 441 | 932 | 512 | 3,444 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (553) | (350) | (917) | (41) | 204 | (1,657) |
Changes in actuarial methods and assumptions that flow directly through income |
(157) |
37 |
106 |
- |
- |
(14) |
Restructuring charge | - | - | - | - | - | - |
Reinsurance transactions, tax related items and other | (41) | 4 | (33) | 5 | 269 | 204 |
Core earnings (post-tax) | $ 1,484 | $ 1,135 | $ 1,285 | $ 968 | $ 39 | $ 4,911 |
Income tax on core earnings (see above) | 203 | 291 | 289 | 149 | (62) | 870 |
Core earnings (pre-tax) | $ 1,687 | $ 1,426 | $ 1,574 | $ 1,117 | $ (23) | $ 5,781 |
Core earnings, CER basis and U.S. dollars – YTD 2023
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2023 | ||||||
Global | Corporate | Total | ||||
Core earnings (post-tax) | $ 1,484 | $ 1,135 | $ 1,285 | $ 968 | $ 39 | $ 4,911 |
CER adjustment(1) | (11) | - | 18 | 8 | 2 | 17 |
Core earnings, CER basis (post-tax) | $ 1,473 | $ 1,135 | $ 1,303 | $ 976 | $ 41 | $ 4,928 |
Income tax on core earnings, CER basis(2) | 199 | 291 | 293 | 149 | (61) | 871 |
Core earnings, CER basis (pre-tax) | $ 1,672 | $ 1,426 | $ 1,596 | $ 1,125 | $ (20) | $ 5,799 |
Core earnings ( Core earnings (post-tax)(3), US $ |
$ 1,104 |
$ 955 | ||||
CER adjustment US $(1) | (24) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 1,080 | $ 955 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q24. |
(3) | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up 2023 year-to-date core earnings. |
Core earnings available to common shareholders
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | |
Core earnings Less: Preferred share dividends and | $ 1,828
56 | $ 1,737
99 | $ 1,754
55 | $ 1,773
99 | $ 1,743
54 | $ 5,319
210 | $ 4,911
204 | $ 6,684
303 |
Core earnings available to common | ||||||||
shareholders | 1,772 | 1,638 | 1,699 | 1,674 | 1,689 | 5,109 | 4,707 | 6,381 |
CER adjustment(1) | - | 5 | 16 | 2 | 16 | 21 | 17 | 19 |
Core earnings available to common |
$ 1,772 |
$ 1,643 |
$ 1,715 |
$ 1,676 |
$ 1,705 |
$ 5,130 |
$ 4,724 |
$ 6,400 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
Core ROE
($ millions, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | |
Core earnings available to common shareholders |
$ 1,772 |
$ 1,638 |
$ 1,699 |
$ 1,674 |
$ 1,689 |
$ 5,109 |
$ 4,707 |
$ 6,381 |
Annualized core earnings available to common shareholders (post-tax) |
$ 7,049 |
$ 6,588 |
$ 6,833 |
$ 6,641 |
$ 6,701 |
$ 6,824 |
$ 6,293 |
$ 6,381 |
Average common shareholders' equity (see below) |
$ 42,609 |
$ 41,947 |
$ 40,984 |
$ 40,563 |
$ 39,897 |
$ 41,847 |
$ 40,081 |
$ 40,201 |
Core ROE (annualized) (%) | 16.6 % | 15.7 % | 16.7 % | 16.4 % | 16.8 % | 16.3 % | 15.7 % | 15.9 % |
Average common shareholders' | ||||||||
equity | ||||||||
Total shareholders' and other equity | $ 49,573 | $ 48,965 | $ 48,250 | $ 47,039 | $ 47,407 | $ 49,573 | $ 47,407 | $ 47,039 |
Less: Preferred shares and other equity | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 |
Common shareholders' equity | $ 42,913 | $ 42,305 | $ 41,590 | $ 40,379 | $ 40,747 | $ 42,913 | $ 40,747 | $ 40,379 |
Average common shareholders' equity |
$ 42,609 |
$ 41,947 |
$ 40,984 |
$ 40,563 |
$ 39,897 |
$ 41,847 |
$ 40,081 |
$ 40,201 |
Core earnings available to common shareholders excluding the impact of GMT
For the three months ended September 30, 2024 ($ millions and post-tax) |
2024 |
Core earnings available to common shareholders | $ 1,772 |
Less: GMT included in core earnings | (61) |
Core earnings available to common shareholders excluding the impact GMT | $ 1,833 |
CSM and post-tax CSM information
($ millions pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
As at | Sept 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sept 30, 2023 |
CSM | $ 22,213 | $ 21,760 | $ 22,075 | $ 21,301 | $ 18,149 |
Less: CSM for NCI | 1,283 | 1,002 | 986 | 861 | 780 |
CSM, net of NCI | $ 20,930 | $ 20,758 | $ 21,089 | $ 20,440 | $ 17,369 |
CER adjustment(1) | - | 218 | 207 | 427 | 152 |
CSM, net of NCI, CER basis | $ 20,930 | $ 20,976 | $ 21,296 | $ 20,867 | $ 17,521 |
Post-tax CSM CSM |
$ 22,213 |
$ 21,760 |
$ 22,075 |
$ 21,301 |
$ 18,149 |
Marginal tax rate on CSM | (2,488) | (2,576) | (2,650) | (2,798) | (2,474) |
Post-tax CSM | $ 19,725 | $ 19,184 | $ 19,425 | $ 18,503 | $ 15,675 |
CSM, net of NCI | $ 20,930 | $ 20,758 | $ 21,089 | $ 20,440 | $ 17,369 |
Marginal tax rate on CSM net of NCI | (2,335) | (2,468) | (2,542) | (2,692) | (2,377) |
Post-tax CSM net of NCI | $ 18,595 | $ 18,290 | $ 18,547 | $ 17,748 | $ 14,992 |
(1) | The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position in effect for 3Q24. |
New business CSM(1) detail, CER basis
($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | |||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | ||
New business CSM | |||||||||
$ 254 | $ 200 | $ 168 | $ 199 | $ 167 | $ 622 | $ 477 | $ 676 | ||
86 | 90 | 48 | 42 | 29 | 224 | 84 | 126 | ||
Asia Other | 253 | 188 | 275 | 173 | 206 | 716 | 574 | 747 | |
International High Net Worth | 231 | ||||||||
Mainland | 138 | ||||||||
244 | |||||||||
87 | |||||||||
Other Emerging Markets | 47 | ||||||||
593 | 478 | 491 | 414 | 402 | 1,562 | 1,135 | 1,549 | ||
95 | 76 | 70 | 70 | 51 | 241 | 154 | 224 | ||
71 | 74 | 97 | 142 | 54 | 242 | 252 | 394 | ||
Total new business CSM | $ 759 | $ 628 | $ 658 | $ 626 | $ 507 | $ 2,045 | $ 1,541 | $ 2,167 | |
New business CSM, CER adjustment(2),(3) | |||||||||
$ - | $ - | $ 1 | $ 1 | $ 3 | $ 1 | $ 7 | $ - | ||
- | 4 | 1 | (1) | (1) | 5 | (5) | (8) | ||
Asia Other | - | 2 | 5 | 2 | 6 | 7 | 5 | (5) | |
International High Net Worth | 1 | ||||||||
Mainland | (1) | ||||||||
- | |||||||||
(4) | |||||||||
Other Emerging Markets | (1) | ||||||||
- | 6 | 7 | 2 | 8 | 13 | 7 | (13) | ||
- | - | - | - | 1 | - | - | - | ||
- | (1) | 1 | (1) | 1 | - | 1 | (1) | ||
Total new business CSM | $ - | $ 5 | $ 8 | $ 1 | $ 10 | $ 13 | $ 8 | $ (14) | |
New business CSM, CER basis | |||||||||
$ 254 | $ 200 | $ 169 | $ 200 | $ 170 | $ 623 | $ 484 | $ 676 | ||
86 | 94 | 49 | 41 | 28 | 229 | 79 | 118 | ||
Asia Other | 253 | 190 | 280 | 175 | 212 | 723 | 579 | 742 | |
International High Net Worth | 232 | ||||||||
Mainland | 137 | ||||||||
244 | |||||||||
83 | |||||||||
Other Emerging Markets | 46 | ||||||||
593 | 484 | 498 | 416 | 410 | 1,575 | 1,142 | 1,536 | ||
95 | 76 | 70 | 70 | 52 | 241 | 154 | 224 | ||
71 | 73 | 98 | 141 | 55 | 242 | 253 | 393 | ||
Total new business CSM, CER basis | $ 759 | $ 633 | $ 666 | $ 627 | $ 517 | $ 2,058 | $ 1,549 | $ 2,153 |
(1) | New business CSM is net of NCI. |
(2) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(3) | New business CSM for Asia Other is reported by country annually, on a full year basis. Other Emerging Markets within Asia Other include |
Net income financial measures on a CER basis
($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | |
Net income (loss) attributed to shareholders: | ||||||||
$ 827 | $ 363 | $ 615 | $ 84 | $ 733 | $ 1,348 | |||
430 | 79 | 273 | 365 | 290 | 782 | 826 | 1,191 | |
5 | 135 | (108) | 198 | 72 | 32 | 441 | 639 | |
Global WAM | 498 | 350 | 365 | 365 | 318 | 1,213 | 932 | 1,297 |
Corporate and Other | 79 | (104) | (27) | 116 | 249 | (52) | 512 | 628 |
Total net income (loss) attributed to shareholders | 1,839 | 1,042 | 866 | 1,659 | 1,013 | 3,747 | 3,444 | 5,103 |
Preferred share dividends and other equity distributions | (56) | (99) | (55) | (99) | (54) | (210) | (204) | (303) |
Common shareholders' net income (loss) | $ 1,783 | $ 811 | $ 959 | $ 4,800 | ||||
CER adjustment(1) | ||||||||
$ - | $ (10) | $ 3 | $ 1 | $ - | $ (7) | $ 17 | $ 18 | |
- | 1 | 2 | (5) | 3 | 3 | 2 | (3) | |
- | (1) | 5 | (2) | - | 4 | 13 | 11 | |
Global WAM | - | (1) | 3 | - | 4 | 2 | 8 | 8 |
Corporate and Other | - | (1) | - | - | (7) | (1) | (20) | (20) |
Total net income (loss) attributed to shareholders | - | (12) | 13 | (6) | - | 1 | 20 | 14 |
Preferred share dividends and other equity distributions | - | - | - | - | - | - | - | - |
Common shareholders' net income (loss) | $ - $ | (12) $ | 13 $ | (6) $ | - | $ 1 | $ 20 | $ 14 |
Net income (loss) attributed to shareholders, CER basis | ||||||||
$ 827 | $ 366 | $ 616 | $ 84 | $ 750 | $ 1,366 | |||
430 | 80 | 275 | 360 | 293 | 785 | 828 | 1,188 | |
5 | 134 | (103) | 196 | 72 | 36 | 454 | 650 | |
Global WAM | 498 | 349 | 368 | 365 | 322 | 1,215 | 940 | 1,305 |
Corporate and Other | 79 | (105) | (27) | 116 | 242 | (53) | 492 | 608 |
Total net income (loss) attributed to shareholders, CER | ||||||||
basis | 1,839 | 1,030 | 879 | 1,653 | 1,013 | 3,748 | 3,464 | 5,117 |
Preferred share dividends and other equity distributions, CER | (56) | (99) | (55) | (99) | (54) | (210) | (204) | (303) |
Common shareholders' net income (loss), CER basis | $ 1,783 | $ 824 | $ 959 | $ 3,538 | $ 4,814 | |||
Asia net income attributed to shareholders, U.S. dollars | ||||||||
Asia net income (loss) attributed to shareholders, US $(2) | $ 606 | $ 270 | $ 452 | $ 63 | $ 543 | $ 995 | ||
CER adjustment, US $(1) | - | (5) | (2) | (1) | (1) | (7) | 6 | 5 |
Asia net income (loss) attributed to shareholders, U.S. $, CER basis(1) |
$ 606 | $ 419 |
$ 268 |
$ 451 |
$ 62 |
|
$ 549 |
$ 1,000 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q24. |
(2) |
Adjusted book value
As at ($ millions) | Sept 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sept 30, 2023 |
Common shareholders' equity | $ 42,913 | $ 42,305 | $ 41,590 | $ 40,379 | $ 40,747 |
Post-tax CSM, net of NCI | 18,595 | 18,290 | 18,547 | 17,748 | 14,992 |
Adjusted book value | $ 61,508 | $ 60,595 | $ 60,137 | $ 58,127 | $ 55,739 |
Reconciliation of Global WAM core earnings to core EBITDA
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | |
Global WAM core earnings (post-tax) | $ 499 | $ 399 | $ 357 | $ 353 | $ 361 | $ 1,255 | $ 968 | $ 1,321 |
Add back taxes, acquisition costs, other expenses | ||||||||
Core income tax (expenses) recoveries (see | 6 | 46 | 58 | 55 | 59 | 110 | 149 | 204 |
Amortization of deferred acquisition costs and | 48 | 49 | 42 | 45 | 41 | 139 | 121 | 166 |
Amortization of deferred sales commissions | 19 | 19 | 20 | 21 | 19 | 58 | 59 | 80 |
Core EBITDA | $ 572 | $ 513 | $ 477 | $ 474 | $ 480 | $ 1,562 | $ 1,297 | $ 1,771 |
CER adjustment(1) | - | (2) | 4 | (1) | 5 | 2 | 10 | 9 |
Core EBITDA, CER basis | $ 572 | $ 511 | $ 481 | $ 473 | $ 485 | $ 1,564 | $ 1,307 | $ 1,780 |
(1) The impact of updating foreign exchange rates to that which was used in 3Q24. |
Core EBITDA margin and core revenue
Quarterly Results | YTD Results | Full Year | ||||||
($ millions, unless otherwise stated) | 3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 |
Core EBITDA margin | ||||||||
Core EBITDA | $ 572 | $ 513 | $ 477 | $ 474 | $ 480 | $ 1,562 | $ 1,297 | $ 1,771 |
Core revenue | $ 2,055 | $ 1,948 | $ 1,873 | $ 1,842 | $ 1,783 | $ 5,876 | $ 5,261 | $ 7,103 |
Core EBITDA margin | 27.8 % | 26.3 % | 25.5 % | 25.7 % | 26.9 % | 26.6 % | 24.7 % | 24.9 % |
Global WAM core revenue | ||||||||
Other revenue per financial statements | $ 1,928 | $ 1,849 | $ 1,808 | $ 1,719 | $ 1,645 | $ 5,585 | $ 5,027 | $ 6,746 |
Less: Other revenue in segments other than Global | ||||||||
WAM | 53 | 40 | 58 | 31 | (64) | 151 | 6 | 37 |
Other revenue in Global WAM (fee income) | $ 1,875 | $ 1,809 | $ 1,750 | $ 1,688 | $ 1,709 | $ 5,434 | $ 5,021 | $ 6,709 |
Investment income per financial statements | $ 4,487 | $ 4,261 | $ 4,251 | $ 4,497 | $ 4,028 | $ 16,180 | ||
Realized and unrealized gains (losses) on assets | ||||||||
supporting insurance and investment contract | ||||||||
liabilities per financial statements | 1,730 | 564 | 538 | 2,674 | (2,430) | 2,832 | 464 | 3,138 |
Total investment income | 6,217 | 4,825 | 4,789 | 7,171 | 1,598 | 15,831 | 12,147 | 19,318 |
Less: Investment income in segments other than | ||||||||
Global WAM | 5,991 | 4,687 | 4,649 | 6,941 | 1,578 | 15,327 | 11,945 | 18,886 |
Investment income in Global WAM | $ 226 | $ 138 | $ 140 | $ 230 | $ 20 | $ 504 | $ 202 | $ 432 |
Total other revenue and investment income in Global | ||||||||
WAM | $ 2,101 | $ 1,947 | $ 1,890 | $ 1,918 | $ 1,729 | $ 5,938 | $ 5,223 | $ 7,141 |
Less: Total revenue reported in items excluded from | ||||||||
core earnings | ||||||||
Market experience gains (losses) | 33 | (9) | 8 | 63 | (54) | 32 | (35) | 28 |
Revenue related to integration and acquisitions | 13 | 8 | 9 | 13 | - | 30 | (3) | 10 |
Global WAM core revenue | $ 2,055 | $ 1,948 | $ 1,873 | $ 1,842 | $ 1,783 | $ 5,876 | $ 5,261 | $ 7,103 |
Core expenses
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q24 | 2Q24 | 1Q24 | 4Q23 | 3Q23 | 2024 | 2023 | 2023 | |
Core expenses | ||||||||
General expenses - Statements of Income | $ 1,204 | $ 1,225 | $ 1,102 | $ 1,180 | $ 1,042 | $ 3,531 | $ 3,150 | $ 4,330 |
Directly attributable acquisition expense for | 36 | 39 | 38 | 42 | 37 | 113 | 105 | 147 |
Directly attributable maintenance expense(1) | 509 | 509 | 539 | 565 | 544 | 1,557 | 1,640 | 2,205 |
Total expenses | 1,749 | 1,773 | 1,679 | 1,787 | 1,623 | 5,201 | 4,895 | 6,682 |
Less: General expenses included in items | ||||||||
Restructuring charge | 25 | - | - | 46 | - | 25 | - | 46 |
Integration and acquisition | - | 57 | - | 8 | - | 57 | - | 8 |
Legal provisions and Other expenses | 8 | 3 | 6 | 8 | 1 | 17 | 70 | 78 |
Total | 33 | 60 | 6 | 62 | 1 | 99 | 70 | 132 |
Core expenses | $ 1,716 | $ 1,713 | $ 1,673 | $ 1,725 | $ 1,622 | $ 5,102 | $ 4,825 | $ 6,550 |
CER adjustment(2) | - | 1 | 11 | 2 | 12 | 12 | 19 | 21 |
Core expenses, CER basis | $ 1,716 | $ 1,714 | $ 1,684 | $ 1,727 | $ 1,634 | $ 5,114 | $ 4,844 | $ 6,571 |
Total expenses | $ 1,749 | $ 1,773 | $ 1,679 | $ 1,787 | $ 1,623 | $ 5,201 | $ 4,895 | $ 6,682 |
CER adjustment(2) | - | 1 | 11 | 2 | 12 | 12 | 19 | 21 |
Total expenses, CER basis | $ 1,749 | $ 1,774 | $ 1,690 | $ 1,789 | $ 1,635 | $ 5,213 | $ 4,914 | $ 6,703 |
(1) Expenses are components of insurance service expenses on the Statements of Income that flow directly through income. (2) The impact of updating foreign exchange rates to that which was used in 3Q24. |
Core earnings contribution from highest potential businesses
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD Results | |
2024 | 2023 |
Core earnings highest potential businesses(1) $ 3,745 | $ 2,950 |
Core earnings - All other businesses 1,574 | 1,961 |
Core earnings 5,319 | 4,911 |
Items excluded from core earnings (1,572) | (1,467) |
Net income (loss) attributed to shareholders $ 3,747 | $ 3,444 |
Highest potential businesses core earnings contribution | 60 % |
(1) Includes core earnings from Asia and Global WAM segments, Canada Group Benefits, and behavioral insurance products. |
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the
The forward-looking statements in this document include, but are not limited to, statements with respect to our ability to achieve our medium-term financial and operating targets, and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified fair value through other comprehensive income; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, and in the "Risk Management" note to the Consolidated Financial Statements in our most recent annual and interim reports, as well as elsewhere in our filings with Canadian and
The forward looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/manulife-reports-third-quarter-2024-results-302297938.html
SOURCE The Manufacturers Life Insurance Company
FAQ
What was Manulife's (MFC) core earnings for Q3 2024?
How much did Manulife's (MFC) APE sales grow in Q3 2024?
What was Manulife's (MFC) net income in Q3 2024?